TNNT2 Gene Cardiomyopathy familial hypertrophic type 2 Genetic Test
Are you looking for TNNT2 Gene Cardiomyopathy familial hypertrophic type 2 Genetic Test in UAE? Look no further! DNA Labs UAE offers this genetic test at a cost of AED 4400.0.
Test Components
- Price: AED 4400.0
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Cardiovascular Pneumology Disorders
- Doctor: Cardiologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the TNNT2 Gene Cardiomyopathy familial hypertrophic type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with TNNT2 Gene Cardiomyopathy familial hypertrophic type 2 NGS Genetic DNA Test gene TNNT2.
Test Details
The TNNT2 gene cardiomyopathy familial hypertrophic type 2 NGS genetic test is a diagnostic test used to detect mutations in the TNNT2 gene. This gene is associated with familial hypertrophic cardiomyopathy (FHC), a genetic disorder characterized by the thickening of the heart muscle.
The test is performed using next-generation sequencing (NGS) technology, which allows for the analysis of multiple genes simultaneously. It involves the extraction of DNA from a blood sample, followed by sequencing and analysis of the TNNT2 gene to identify any mutations or variants that may be present.
This genetic test is used to confirm a diagnosis of familial hypertrophic cardiomyopathy and to determine the specific genetic mutation responsible for the condition. It can also be used for carrier testing in individuals with a family history of the disorder.
The results of the test can help guide treatment decisions and management of the condition, as well as provide information about the risk of passing the gene mutation to future generations. It is recommended to undergo genetic counseling before and after the test to fully understand the implications of the results and discuss potential treatment options or reproductive choices.
Test Name | TNNT2 Gene Cardiomyopathy familial hypertrophic type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cardiovascular Pneumology Disorders |
Doctor | Cardiologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for TNNT2 Gene Cardiomyopathy, familial hypertrophic type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TNNT2 Gene Cardiomyopathy, familial hypertrophic type 2 NGS Genetic DNA Test gene TNNT2 |
Test Details |
TNNT2 gene cardiomyopathy, familial hypertrophic type 2 NGS genetic test is a diagnostic test that is used to detect mutations in the TNNT2 gene. This gene is associated with familial hypertrophic cardiomyopathy (FHC), which is a genetic disorder characterized by the thickening of the heart muscle. The test is performed using next-generation sequencing (NGS) technology, which allows for the analysis of multiple genes simultaneously. It involves the extraction of DNA from a blood sample, followed by sequencing and analysis of the TNNT2 gene to identify any mutations or variants that may be present. This genetic test is used to confirm a diagnosis of familial hypertrophic cardiomyopathy and to determine the specific genetic mutation responsible for the condition. It can also be used for carrier testing in individuals with a family history of the disorder. The results of the test can help guide treatment decisions and management of the condition, as well as provide information about the risk of passing the gene mutation to future generations. Genetic counseling is often recommended before and after undergoing this test to help individuals understand the implications of the results and to discuss any potential treatment options or reproductive choices. |